跳至主要内容
临床试验/CTRI/2024/03/064412
CTRI/2024/03/064412尚未招募2 期

Efficacy Of Takra Haritaki And Palashadi Yavagu In The Management Of Grahani Roga (Irritable Bowel Syndrome) - An Open Label Single Arm Trial - Nil

All India Institute Of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • A)IBD-10-CM Code IBD 2024 ICD-10-CM Diagnosis Code K58.90
  • B)Age: 21-60 Years
  • C)Gender-Both Males & Females
  • D)Patients Having Pratyatma Lakshana Of Grahani Roga Especially –
  • 1)Atisrushtam Or Ativibadhham Or Atidravam Malapravritti (Altered Bowel Habits) With Or Without Other Symptoms (Trushna, Arochaaka, Vairasya, Praseka, Tamaka, Shoona Pada, Shoona Kara, Asthi-Parva Ruja, Chhardi, Jwara, Louha-Ama-Gandhi Tiktamlodgar) &
  • 2)The Patients Who Are Diagnosed With IBS According To Standard Rome Iv Criteria.
  • E)Willing To Give Written Informed Consent.

排除标准

  • 1)Previously Diagnosed Cases And History Of Ulcerative Colitis, Crohn’s Disease, Gastric Ulcerations, Intestinal Tuberculosis And Other Inflammatory Bowel Conditions.
  • 2)Mixed Infection With Parasites Such As Round Worms, Hook Worms, & Lactose Intolerance Patients.
  • 3)Patients With Evidence Of Malignancy.
  • 4)Patents With Uncontrolled Diabetes Mellitus, Poorly Controlled Hypertension And Any Other Autoimmune Disorders.
  • 5)Abuse Of Drug Or Alcohol.
  • 6)Presence Of Other Somatic Or Mental Disorder Requiring Medication.
  • 7)Patients On Prolonged Medication With Nsaids, Analgesics Or Any Other Drugs That May Have An Influence On The Outcome Of The Study.
  • 8)Pregnant & Lactating Women.

研究者

相似试验